APA (7th ed.) Citation

Kumar, S., Khuroo, A., Gurule, S. J., Mehra, S., Tiwari, H. K., Zala, Y., . . . Khandhedia, C. (2026). Gabapentin Extended Release Tablets in Healthy Subjects Under Fed Conditions: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study. Drugs in R&D, 1. https://doi.org/10.1007/s40268-026-00547-8

Chicago Style (17th ed.) Citation

Kumar, Sudershan, et al. "Gabapentin Extended Release Tablets in Healthy Subjects Under Fed Conditions: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study." Drugs in R&D 2026: 1. https://doi.org/10.1007/s40268-026-00547-8.

MLA (9th ed.) Citation

Kumar, Sudershan, et al. "Gabapentin Extended Release Tablets in Healthy Subjects Under Fed Conditions: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Comparative Bioavailability Study." Drugs in R&D, 2026, p. 1, https://doi.org/10.1007/s40268-026-00547-8.